by Monash University Credit: CC0 Public Domain A comprehensive international study, led by Monash University researchers, has definitively found that pregnancy can delay the onset of multiple sclerosis (MS) by more than 3 years. MS is four times more prevalent in women and the finding—which used a global database of more than 70,000 MS patients, run by Monash...
(HealthDay)—For multiple sclerosis (MS) patients with clinically isolated syndrome, lower vitamin D and smoking predict worse long-term cognitive function and neuronal integrity, according to a study published online April 16 in Neurology. Marianna Cortese, M.D., Ph.D., from the University of Bergen in Norway, and colleagues conducted a study involving 278 patients with clinically isolated syndrome...
by Thomas Jefferson University Multiple sclerosis (MS), characterized by increasing muscle weakness and paralysis, has a number of treatments that help stall progression of the disease when used early on in the disease. But the current treatments can hardly reverse damage that has already occurred in brain cells called neurons. New research suggests that a...
The U.S. Food and Drug Administration has approved ozanimod, an immune-modulating therapy invented at Scripps Research, for the treatment of adults with relapsing forms of multiple sclerosis. The drug is also in advanced clinical development for adults and children with moderate-to-severe ulcerative colitis and Crohn’s disease. In patient studies supporting ozanimod’s New Drug Application, those...
by The Scripps Research Institute The U.S. Food and Drug Administration has approved ozanimod, an immune-modulating therapy invented at Scripps Research, for the treatment of adults with relapsing forms of multiple sclerosis. The drug is also in advanced clinical development for adults and children with moderate-to-severe ulcerative colitis and Crohn’s disease. In patient studies supporting...
by University of Texas M. D. Anderson Cancer Center Medical experts have always known myelin, the protective coating of nerve cells, to be metabolically inert. A study led by The University of Texas MD Anderson Cancer Center has found that myelin is surprisingly dynamic, a discovery that has implications for treatment of multiple sclerosis and...
by University of North Carolina at Chapel Hill School of Medicine People with multiple sclerosis (MS) often have a greatly increased risk of falling and injuring themselves even when they feel they’re able to walk normally. Now a team led by scientists from the UNC School of Medicine has demonstrated what could be a relatively...
by University of California – San Diego Multiple sclerosis (MS) is a progressive, chronic disorder in which the body’s immune system attacks the central nervous system, resulting in multiple adverse effects, from numbness, fatigue and impaired speech to loss of muscle control and vision. There is no cure for MS; treatment focuses upon managing symptoms...
by Jim Fessenden, University of Massachusetts Medical School New research by Dorothy P. Schafer, Ph.D., at the University of Massachusetts Medical School, reveals the molecular process in which synaptic connections in the brain are damaged in multiple sclerosis and how this contributes to neurodegenerative symptoms. The paper, published in Immunity, also shows how gene therapy...
by Kessler Foundation Kessler Foundation researchers reported results of a study of deficits in prospective memory in individuals with multiple sclerosis (MS) that may contribute to difficulties with everyday life activities. The article, “Time-based prospective memory is associated with functional performance in persons with MS,” was epublished on September 23, 2019 by the Journal of the...
